Monte Rosa Therapeutics Inc (GLUE) — Working Capital to Net Assets Ratio

Latest as of March 2026: 116.2%

Monte Rosa Therapeutics Inc (GLUE) has a Working Capital to Net Assets ratio of 116.2% as of March 2026. Working capital of $606.51 Million (current assets of $677.55 Million minus current liabilities of $71.04 Million) is measured against net assets of $521.92 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Monte Rosa Therapeutics Inc net asset quality index to measure how much of total assets are equity-financed.

WC/NA Ratio

116.2%
Working Capital / Net Assets

Working Capital

$606.51 Million
USD

Current Assets

$677.55 Million
USD

Current Liabilities

$71.04 Million
USD

Monte Rosa Therapeutics Inc Working Capital to Net Assets (2019–2025)

This chart shows how Monte Rosa Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 116.2%, reflecting working capital of $606.51 Million against net assets of $521.92 Million USD. Check Monte Rosa Therapeutics Inc (GLUE) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Monte Rosa Therapeutics Inc (2019–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Monte Rosa Therapeutics Inc from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Monte Rosa Therapeutics Inc (GLUE) total market value.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 141.2% $328.97 Million $233.06 Million $393.19 Million $64.21 Million ▲ +42.3 pp
2024 98.9% $220.49 Million $222.94 Million $377.44 Million $156.95 Million ▼ -6.9 pp
2023 105.8% $189.62 Million $179.25 Million $236.21 Million $46.59 Million ▲ +13.6 pp
2022 92.2% $250.32 Million $271.41 Million $275.89 Million $25.57 Million ▼ -3.3 pp
2021 95.5% $332.03 Million $347.51 Million $348.67 Million $16.64 Million ▲ +124.9 pp
2020 -29.4% $14.32 Million $-48.73 Million $43.59 Million $29.27 Million ▲ +15.6 pp
2019 -45.0% $5.47 Million $-12.15 Million $9.76 Million $4.29 Million
pp = percentage points